Optimizing Your Solid Dose Drug Delivery

Purple tablet releasing the active ingredient represented by pink circles.

Whether it is sustained release or oral disintegration, oral solid dose or dry inhaled powders. Our particle-optimized excipients have been specifically developed to provide an excellent performance in solid drug delivery, targeting multiple administration routes and different release kinetics, and include:

Options for modifying release kinetics, such as orally disintegrating tablets and sustained-release solid oral formulations
Specialized excipients for different routes of administration, including dry powder inhalation

All supported by the Emprove^® Program with comprehensive documentation to speed up your way to the market. Whenever applicable, our products are compliant with the major pharmacopeias.

Explore how you can improve productivity and performance.

EXPLORE HOW YOU CAN IMPROVE PRODUCTIVITY AND PERFORMANCE

A clock and a yellow pill, representing a defined release time of the dosage form.

Sustained-Release Solid Dose Formulations

Reliable sustained drug delivery over long release periods with our functional, polyvinyl alcohol (PVA)-based excipient to increase efficacy and bioavailability while reducing side effects and the risk of dose dumping.

Parteck^® SRP 80 Excipient

A close up of drug powder inhalers on a yellow background.

A High-Performance Synthetic Carrier

Our versatile carrier option for your dry powder inhalation (DPI) formulation. Engineered from mannitol and designed to improve the flow and release characteristics of APIs in drugs delivered via dry, inhaled powders.

Parteck^® M DPI Excipient

A hand holding a purple and pink stopwatch on a yellow background.

Directly Compressible Excipient for ODTs

Produce top quality, rapid acting tablets more cost effectively than ever. Robust tablets, rapid disintegration, excellent mouthfeel combined with superior performance in direct compression and continuous manufacturing.

Parteck^® ODT Excipient

A pair of hands holding a white tablet in each hand.

Mask Bitter Aftertaste for a Sweeter Pill to Swallow

Pleasant taste can make a difference in patient compliance and, as a result, in therapeutic benefit. Our high intensity sweeteners Neotame, Sucralose micronized and Sucralose granular mask bitter aftertaste and medical off-notes with ease.

Related Product Resources

Download: Formulation Handbook
In this formulation handbook, we have compiled information and formulation examples that can help you when developing your formulation.
Parteck^® SRP 80 White Paper: New Opportunities for Oral Sustained Release Formulations with Polyvinyl Alcohol
This white paper describes the use of PVA-based Parteck^® SRP 80, a functional excipient specifically developed for matrix-based sustained release oral solid dose formulations.
Parteck^® SRP 80 Brochure: Take Control of Sustained Drug Release
Achieve consistent API release. Reduce risk of dose dumping.
Parteck^® M DPI Brochure: Take a Deep Breath
Enhance API delivery to the lungs.
Parteck^® M DPI White Paper: Considerations for Dosing Accuracy in a New Carrier for Dry Powder Inhalation
Inhalation drug delivery methods are attractive, noninvasive routes when rapid onset of action, minimal side effects and excellent bioavailability are desired.
Parteck^® ODT White Paper: How to select the Optimal ODT Excipient System
This white paper explores several factors to be considered when evaluating and selecting an ODT excipient system suitable for direct compression.
Parteck^® ODT Brochure: Right Here – Right Now
Combining rapid disintegration with exceptional strength for your ODT formulation.
Sweeteners Brochure: Two Ways to Ace the Taste Test
Achieve stable formulations and clean, sugar-like taste with our high-intensity sweeteners.
Article: Active Pharmaceutical Ingredient (API) Stability in Solid Dose Formulation
This article describes the use of excipients to help address API stability issues.

Page 1 sur 2

Related Webinars

A digital illustration of a laptop displaying a simplistic human figure next to a pink rectangle, all set against a yellow background.

PVA for Sustained Release: Theory and Practice

This webinar presents PVA, a fully synthetic polymer, for optimized sustained release matrix formulations.

API Stability in Solid Dose Formulation "The Myth of Inert Excipients"

This webinar explores how the choice of excipients can improve API stability in a solid dosage drug formulation.

The High Intensity Sweeteners Neotame and Sucralose: Two Ways to Ace the Patient's Taste Test

We present our new toolbox of two high performance sweeteners and focus on aspects of stability, safety, the application in various dosage forms, and market perception.